Related references
Note: Only part of the references are listed.A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma
Janice M. Mehnert et al.
PIGMENT CELL & MELANOMA RESEARCH (2018)
The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology
Akinori Kawakami et al.
LABORATORY INVESTIGATION (2017)
Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells
Franziska Baenke et al.
MOLECULAR ONCOLOGY (2016)
Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells
Jessica L. F. Teh et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Vemurafenib resistance reprograms melanoma cells towards glutamine dependence
Jenny E. Hernandez-Davies et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma Progression
Stephen A. Rosenberg et al.
TRANSLATIONAL ONCOLOGY (2015)
Glutamate and asparagine cataplerosis underlie glutamine addiction in melanoma
Boris Ratnikov et al.
ONCOTARGET (2015)
Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
Luika A. Timmerman et al.
CANCER CELL (2013)
Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells
J. J. Martino et al.
ONCOGENE (2013)
Somatic Mutations in GRM1 in Cancer Alter Metabotropic Glutamate Receptor 1 Intracellular Localization and Signaling
Jessica L. Esseltine et al.
MOLECULAR PHARMACOLOGY (2013)
Intrathecal Injection of Metabotropic Glutamate Receptor Subtype 3 and 5 Agonist/Antagonist Attenuates Bone Cancer Pain by Inhibition of Spinal Astrocyte Activation in a Mouse Model
Bing-xu Ren et al.
ANESTHESIOLOGY (2012)
Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer
Cecilia L. Speyer et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Molecular Pathways: Dysregulated Glutamatergic Signaling Pathways in Cancer
Todd D. Prickett et al.
CLINICAL CANCER RESEARCH (2012)
Serum Glutamate Levels Correlate with Gleason Score and Glutamate Blockade Decreases Proliferation, Migration, and Invasion and Induces Apoptosis in Prostate Cancer Cells
Shahriar Koochekpour et al.
CLINICAL CANCER RESEARCH (2012)
Functional Effects of GRM1 Suppression in Human Melanoma Cells
Janet Wangari-Talbot et al.
MOLECULAR CANCER RESEARCH (2012)
CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc- and Thereby Promotes Tumor Growth
Takatsugu Ishimoto et al.
CANCER CELL (2011)
Glutamatergic Pathway Targeting in Melanoma: Single-Agent and Combinatorial Therapies
Hwa Jin Lee et al.
CLINICAL CANCER RESEARCH (2011)
Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma
Todd D. Prickett et al.
NATURE GENETICS (2011)
Exome sequencing identifies GRIN2A as frequently mutated in melanoma
Xiaomu Wei et al.
NATURE GENETICS (2011)
Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice
Kyu Yeong Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Cancer cell lines release glutamate into the extracellular environment
Eric P. Seidlitz et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
A Phase 0 Trial of Riluzole in Patients with Resectable Stage III and IV Melanoma
Dana Yip et al.
CLINICAL CANCER RESEARCH (2009)
Keratinocytes: a source of the transmitter L-glutamate in the epidermis
Matthias Fischer et al.
EXPERIMENTAL DERMATOLOGY (2009)
Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/β-catenin pathway
R-S Chen et al.
ONCOGENE (2009)
Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1
Elena Fumagalli et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
A role for glutamate in growth and invasion of primary brain tumors
Harald Sontheimer
JOURNAL OF NEUROCHEMISTRY (2008)
Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma
Y. Ohtani et al.
ONCOGENE (2008)
Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation
Seung-Shick Shin et al.
PIGMENT CELL & MELANOMA RESEARCH (2008)
Autocrine glutamate signaling promotes glioma cell invasion
Susan A. Lyons et al.
CANCER RESEARCH (2007)
Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma
Jin Namkoong et al.
CANCER RESEARCH (2007)
Glutamate receptors on human melanocytes regulate the expression of MiTF
MJ Hoogduijn et al.
PIGMENT CELL RESEARCH (2006)
Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance
Y Huang et al.
CANCER RESEARCH (2005)
Slc7a11 gene controls production of pheomelanin pigment and proliferation of cultured cells
S Chintala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia
PM Pollock et al.
NATURE GENETICS (2003)
Oxidative glutamate toxicity involves mitochondrial dysfunction and perturbation of intracellular Ca2+ homeostasis
CF Pereira et al.
NEUROSCIENCE RESEARCH (2000)
Share Paper
